Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Platform® Acetabular System

K-Number: K220483 · 2022-09-23

Decision Date2022-09-23
Product CodeLZO
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

Platform® Acetabular System is a medical device manufactured by Total Joint Orthopedics, Inc.. It received FDA 510(k) clearance on 2022-09-23 under approval number K220483. The device is classified under product code LZO. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Platform® Acetabular System?

Platform® Acetabular System is a medical device that received FDA 510(k) clearance on 2022-09-23. It is manufactured by Total Joint Orthopedics, Inc.. The 510(k) number is K220483.

When was Platform® Acetabular System approved by the FDA?

Platform® Acetabular System received FDA 510(k) clearance on 2022-09-23, under approval number K220483.

What company makes Platform® Acetabular System?

Platform® Acetabular System is manufactured by Total Joint Orthopedics, Inc..

What is the FDA product code for Platform® Acetabular System?

The FDA product code for Platform® Acetabular System is LZO.

Related Clinical Trials

Related PubMed Literature

Other Devices by Total Joint Orthopedics, Inc.

View all 11 devices →

Related Devices (Code: LZO)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.